Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26143-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- DUB3 antibody
- Antibody type
- Polyclonal
- Description
- DUB3 antibody (Cat. #26143-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references DUB3 is a MAGEA3 deubiquitinase and a potential therapeutic target in hepatocellular carcinoma.
C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis.
Sarmentosin promotes USP17 and regulates Nrf2-mediated mitophagy and cellular oxidative stress to alleviate APAP-induced acute liver failure.
USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells.
Lysophosphatidic Acid-Induced EGFR Transactivation Promotes Gastric Cancer Cell DNA Replication by Stabilizing Geminin in the S Phase.
Chen Y, Gao F, He Y, Liu M, Quan Y, Zhang P
iScience 2024 Mar 15;27(3):109181
iScience 2024 Mar 15;27(3):109181
C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis.
Huang S, Li J, Wu S, Zheng Z, Wang C, Li H, Zhao L, Zhang X, Huang H, Huang C, Xie Q
Oncogene 2023 Apr;42(17):1333-1346
Oncogene 2023 Apr;42(17):1333-1346
Sarmentosin promotes USP17 and regulates Nrf2-mediated mitophagy and cellular oxidative stress to alleviate APAP-induced acute liver failure.
Jiang Z, Yang X, Han Y, Li J, Hu C, Liu C, Xiao W
Phytomedicine : international journal of phytotherapy and phytopharmacology 2022 Sep;104:154337
Phytomedicine : international journal of phytotherapy and phytopharmacology 2022 Sep;104:154337
USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells.
Su Y, Wu C, Chang Y, Li L, Chen Y, Jia X, Wang X, Lv Y, Yu B, Yuan J
Breast cancer research and treatment 2022 Nov;196(1):31-44
Breast cancer research and treatment 2022 Nov;196(1):31-44
Lysophosphatidic Acid-Induced EGFR Transactivation Promotes Gastric Cancer Cell DNA Replication by Stabilizing Geminin in the S Phase.
Zhao H, Gezi G, Tian X, Jia P, Morigen M, Fan L
Frontiers in pharmacology 2021;12:706240
Frontiers in pharmacology 2021;12:706240
No comments: Submit comment
No validations: Submit validation data